Fig. 2
From: Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
![Fig. 2](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs40035-019-0172-x/MediaObjects/40035_2019_172_Fig2_HTML.png)
Approximate frequency of Lewy pathology reported in other neurodegenerative proteinopathies and in the unimpaired aged population. These estimates do not capture the amount of Lewy pathology present or anatomical distribution of Lewy pathology in relation to the primary pathology, but instead reflect the reporting of the presence of any amount of Lewy pathology in any brain region. Lewy body (LB); multiple system atrophy (MSA); unimpaired aging (Ua), frontotemporal lobe dementia (FTLD), amyotrophic lateral sclerosis (ALS), sporadic Creuzfeldt-Jakob disease (sCJD); Alzheimer’s disease (AD); progressive supranuclear palsy (PSP); corticobasal degeneration (CBD)